STAGE IV LUNG CANCER AJCC V8
Clinical trials for STAGE IV LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Vaccine-Drug combo aims to fight tough lung cancer
Disease control Not yet recruitingThis study tests a combination of a cancer vaccine (CIMAVAX-EGF) and targeted drugs (sotorasib or adagrasib) in about 29 adults with advanced non-small cell lung cancer that has a specific KRAS G12C mutation. The vaccine helps the immune system attack cancer cells, while the drug…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 00:52 UTC
-
Light-activated combo therapy takes on hard-to-treat lung cancer
Disease control Not yet recruitingThis study tests a new treatment for people with advanced non-small cell lung cancer that has stopped responding to standard therapies. The treatment combines a light-activated drug (ASP-1929) with an immunotherapy drug (cemiplimab) to target and kill cancer cells. About 27 adult…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 00:50 UTC